The Urbanek TMJ Device and Protocol announced the official launch of its commercial operations in North America, offering dentists a new way to treat the 10+ million TMD/TMJ sufferers in the United States.
“After more than 4,000 cases treated with a 95% success rate, we’re excited to finally offer this solution nationwide to treat the growing epidemic of TMD. With this FDA-cleared medical device and our comprehensive training and support, dental care providers can now offer their patients an easy and affordable solution,” says CEO and Founder Dr. Anthony Urbanek.
For more information, visit www.UrbanekTMJ.com or register for Dr. Urbanek’s CE webinar here: https://bit.ly/3WHfb2W.
